Cargando…
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study
Autores principales: | Zattoni, F., Marra, G., Kretschmer, A., Preisser, F., Kesch, C., Radtke, J.P., Hoffmann, N., Morlacco, A., Dal Moro, F., Soeterik, T.F., Van Den Bergh, R.C., Barletta, F., Briganti, A., Montorisi, F., Gandaglia, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263108/ http://dx.doi.org/10.1016/S0302-2838(21)01518-9 |
Ejemplares similares
-
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study
por: Zattoni, Fabio, et al.
Publicado: (2021) -
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis
por: Kesch, Claudia, et al.
Publicado: (2022) -
Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021) -
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives
por: Kretschmer, Alexander, et al.
Publicado: (2021) -
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
por: Heidegger, Isabel, et al.
Publicado: (2022)